Viewing Study NCT02552342



Ignite Creation Date: 2024-05-06 @ 7:32 AM
Last Modification Date: 2024-10-26 @ 11:49 AM
Study NCT ID: NCT02552342
Status: UNKNOWN
Last Update Posted: 2015-09-17
First Post: 2015-09-16

Brief Title: Corticosteroid Therapy for Severe Community-Acquired Pneumonia
Sponsor: Peking Union Medical College Hospital
Organization: Peking Union Medical College Hospital

Study Overview

Official Title: Efficacy of Methylprednisolone in Severe Community-acquired PneumoniaA Multi-center Randomized Controlled Trial
Status: UNKNOWN
Status Verified Date: 2015-09
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the present study is to assess the efficacy of methylprednisolone as an adjuvant therapy in patients with severe community-acquired pneumonia CAP PSI 4-5

The hypothesis of the study is that methylprednisolone can decrease the mortality of severe CAP without any significant side effectswith reduction of the time to clinical stability and failure rate of treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None